Unfortunately for Americans, consolidation in the healthcare industry has neither reduced costs nor improved clinical outcomes. 340B nonprofits have faced particular challenges as pharmacy benefit managers (PBMs) interfere with the ways medically underserved Americans receive healthcare.
The market power that PBM and health insurer mega-firms exert in the healthcare system drives up prescription drug costs for all Americans. Nonprofits, which already operate on razor-thin margins, must combat PBM efforts to siphon off drug discount savings that the federal government intended for 340B providers to extend healthcare services to low-income, uninsured Americans.
Read Full Article »